Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction

[1]  U. Günther,et al.  Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis , 2020, JHEP reports : innovation in hepatology.

[2]  J. Pandit,et al.  Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of Fructose. , 2020, Journal of medicinal chemistry.

[3]  Christian M. Metallo,et al.  Fructose stimulated de novo lipogenesis is promoted by inflammation , 2020, Nature Metabolism.

[4]  G. Tesz,et al.  Finding the Sweet Spot: Parsing Tissue-Specific Contributions of Fructose Metabolism. , 2020, Cell metabolism.

[5]  J. Rabinowitz,et al.  The small intestine shields the liver from fructose-induced steatosis , 2020, Nature Metabolism.

[6]  M. Lanaspa,et al.  Deletion of Fructokinase in the Liver or in the Intestine Reveals Differential Effects on Sugar-Induced Metabolic Dysfunction. , 2020, Cell metabolism.

[7]  R. Krauss,et al.  Role of angiopoietin-like protein 3 in sugar-induced dyslipidemia in rhesus macaques: suppression by fish oil or RNAi[S] , 2020, Journal of Lipid Research.

[8]  K. Stanhope,et al.  Dietary fructose and dyslipidemia: new mechanisms involving apolipoprotein CIII. , 2019, Current opinion in lipidology.

[9]  C. Musante,et al.  A mathematical analysis of adaptations to the metabolic fate of fructose in essential fructosuria subjects. , 2018, American journal of physiology. Endocrinology and metabolism.

[10]  M. Birnbaum,et al.  The Small Intestine Converts Dietary Fructose into Glucose and Organic Acids. , 2018, Cell metabolism.

[11]  M. Herman,et al.  Intestinal, but not hepatic, ChREBP is required for fructose tolerance. , 2017, JCI insight.

[12]  S. Noworolski,et al.  Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity. , 2017, Gastroenterology.

[13]  C. Postic,et al.  Sweet Sixteenth for ChREBP: Established Roles and Future Goals. , 2017, Cell metabolism.

[14]  N. Lundbom,et al.  Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity , 2017, Journal of internal medicine.

[15]  C. Kast,et al.  A randomized-controlled clinical trial of high fructose diets from either Robinia honey or free fructose and glucose in healthy normal weight males , 2017 .

[16]  Mi-Sung Kim,et al.  ChREBP regulates fructose-induced glucose production independently of insulin signaling. , 2016, The Journal of clinical investigation.

[17]  C. Okerberg,et al.  The Application of Paraphenylenediamine Staining for Assessment of Phospholipidosis , 2016, Toxicologic pathology.

[18]  M. Herman,et al.  The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis , 2016, Trends in Endocrinology & Metabolism.

[19]  S. Noworolski,et al.  Short-term isocaloric fructose restriction lowers apoC-III levels and yields less atherogenic lipoprotein profiles in children with obesity and metabolic syndrome. , 2016, Atherosclerosis.

[20]  J. Meissen,et al.  Phenotyping hepatocellular metabolism using uniformly labeled carbon-13 molecular probes and LC-HRMS stable isotope tracing. , 2016, Analytical biochemistry.

[21]  S. Noworolski,et al.  Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome , 2016, Obesity.

[22]  C. Fox,et al.  Sugar-sweetened beverage, diet soda, and fatty liver disease in the Framingham Heart Study cohorts. , 2015, Journal of hepatology.

[23]  V. Medici,et al.  A dose-response study of consuming high-fructose corn syrup-sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults. , 2015, The American journal of clinical nutrition.

[24]  M. Schambelan,et al.  Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat. , 2015, The Journal of clinical endocrinology and metabolism.

[25]  D. Bonthron,et al.  Endogenous fructose production and fructokinase activation mediate renal injury in diabetic nephropathy. , 2014, Journal of the American Society of Nephrology : JASN.

[26]  F. Hu,et al.  Added sugar intake and cardiovascular diseases mortality among US adults. , 2014, JAMA internal medicine.

[27]  M. Vos.  Nutrition, nonalcoholic fatty liver disease and the microbiome: recent progress in the field , 2014, Current opinion in lipidology.

[28]  D. Bonthron,et al.  High‐fat and high‐sucrose (western) diet induces steatohepatitis that is dependent on fructokinase , 2013, Hepatology.

[29]  D. Bonthron,et al.  Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome , 2013, Nature Communications.

[30]  J. McGahan,et al.  Effects of Sugar-sweetened Beverages on plasma Acylation Stimulating Protein, Leptin & Adiponectin and Metabolic Parameters , 2013, Obesity.

[31]  M. Empie,et al.  Fructose metabolism in humans – what isotopic tracer studies tell us , 2012, Nutrition & Metabolism.

[32]  Jeanne M Clark,et al.  Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes , 2012, Hepatology.

[33]  D. Bonthron,et al.  Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice , 2012, Proceedings of the National Academy of Sciences.

[34]  B. Cummings,et al.  Fructose‐Fed Rhesus Monkeys: A Nonhuman Primate Model of Insulin Resistance, Metabolic Syndrome, and Type 2 Diabetes , 2011, Clinical and translational science.

[35]  A. Suzuki,et al.  Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease , 2010, Hepatology.

[36]  Lauren E. W. Olsho,et al.  Intake of Added Sugars and Selected Nutrients in the United States, National Health and Nutrition Examination Survey (NHANES) 2003—2006 , 2010, Critical reviews in food science and nutrition.

[37]  A. Abid,et al.  Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. , 2009, Journal of hepatology.

[38]  D. Bonthron,et al.  Ketohexokinase: Expression and Localization of the Principal Fructose-metabolizing Enzyme , 2009, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[39]  Wei Zhang,et al.  Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. , 2009, The Journal of clinical investigation.

[40]  F. Matschinsky,et al.  Assessing the potential of glucokinase activators in diabetes therapy , 2009, Nature Reviews Drug Discovery.

[41]  R. Krauss,et al.  Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women. , 2008, The British journal of nutrition.

[42]  W. Nseir,et al.  Soft drink consumption linked with fatty liver in the absence of traditional risk factors. , 2008, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[43]  Frank B Hu,et al.  Sugar-sweetened beverages and incidence of type 2 diabetes mellitus in African American women. , 2008, Archives of internal medicine.

[44]  Ralph B. D'Agostino,et al.  Soft Drink Consumption and Risk of Developing Cardiometabolic Risk Factors and the Metabolic Syndrome in Middle-Aged Adults in the Community , 2007, Circulation.

[45]  Walter C Willett,et al.  Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. , 2004, JAMA.

[46]  K. Iizuka,et al.  Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[47]  D. Bonthron,et al.  Molecular basis of essential fructosuria: molecular cloning and mutational analysis of human ketohexokinase (fructokinase). , 1994, Human molecular genetics.

[48]  D. Schoeller,et al.  In vivo measurement of fatty acids and cholesterol synthesis using D2O and mass isotopomer analysis. , 1994, The American journal of physiology.

[49]  E. Van Schaftingen,et al.  Fructose 1-phosphate and the regulation of glucokinase activity in isolated hepatocytes. , 1990, European journal of biochemistry.

[50]  W. R. Morrison,et al.  PREPARATION OF FATTY ACID METHYL ESTERS AND DIMETHYLACETALS FROM LIPIDS WITH BORON FLUORIDE--METHANOL. , 1964, Journal of lipid research.

[51]  Z. Laron,et al.  Essential Benign Fructosuria , 1961, Archives of disease in childhood.

[52]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[53]  G. Kraus,et al.  ESSENTIAL FRUCTOSURIA: ITS PATHOPHYSIOLOGY , 1942 .

[54]  C. Kahn,et al.  Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling. , 2018, The Journal of clinical investigation.

[55]  A. Mohan.  WHO recommends reducing intake of 'free sugars' by adults and children. , 2015, The National medical journal of India.

[56]  J. Sievenpiper,et al.  The Role of Fructose, Sucrose and High-fructose Corn Syrup in Diabetes. , 2014, European endocrinology.

[57]  M. Gillum,et al.  The role of the carbohydrate response element-binding protein in male fructose-fed rats. , 2013, Endocrinology.

[58]  J. Girard,et al.  Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver. , 2012, Journal of hepatology.

[59]  E. Ravussin,et al.  De novo lipogenesis in adipose tissue of lean and obese women: application of deuterated water and isotope ratio mass spectrometry , 2000, International Journal of Obesity.

[60]  W. Christie,et al.  Separation of non-polar lipids by high performance liquid chromatography on a cyanopropyl column , 1993 .

[61]  D. Epps,et al.  Rapid separation of lipid classes in high yield and purity using bonded phase columns. , 1985, Journal of lipid research.